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Chimeric or entirely embryonic stem (ES) cell-derived mice (bES miceQ) can be produced by injecting ES cells into diploid (2n) or
tetraploid (4n) host blastocysts, respectively. Usually, between 10 and 15 ES cells are injected into the host blastocyst, but it is not clear how
many of the injected cells contribute to the somatic lineages, thus serve as bfounder cellsQ of the embryo proper. We have used genetically
labeled ES cells to retrospectively determine the number of founder ES cells that generate the somatic lineages of chimeric and of ES mice.
ES cell clones individually labeled with provirus were mixed in equal numbers and injected into 2n or 4n blastocysts to generate chimeric or
ES mice. Southern analysis of DNA from the resulting animals indicated that the somatic lineages were most often derived from one or two
and sometimes from up to three founder ES cells. The number of founder cells was independent of the total number of cells injected into the
host blastocysts. Our results are consistent with the notion that constraints of the host embryo restrict the number of ES cells that can
contribute to a chimeric or an ES mouse.
D 2004 Elsevier Inc. All rights reserved.
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During early development, the cells of the mammalian
embryo are sequentially allocated to different lineages.
The time of lineage allocation is defined as the point in
development when cell mixing between lineages becomes
minimal (McLaren, 1976). For example, at the morula
stage, cells are either allocated to the trophectoderm
lineage or to the ICM, and at the late blastocyst stage,
inner cell mass cells are allocated to the primitive
endoderm or the epiblast which will generate the yolk
sac and the embryo proper, respectively (Rossant et al.,
2003). How many cells serve as founders of each lineage
during mammalian embryogenesis is a fundamental0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: jaenisch@wi.mit.edu (R. Jaenisch).question in biology. Classical experiments in the 1970s
were undertaken to determine how many cells in the
mouse embryo are set aside at the time of allocation to
form a given lineage. The predominant method to
determine the number of founder cells was the generation
of chimeric mice by aggregation of preimplantation
mouse embryos carrying different genetic markers. Based
upon binomial or trinomial calculations, the contribution
of the parental genotypes to the chimeras leads to the
conclusion that the epiblast lineage is formed by a
minimum of three founder cells (Markert and Petters,
1978; Mintz, 1970). However, the use of aggregation
chimeras for deducing cell interactions in normal mam-
malian development has a number of inherent problems
as discussed at the time by others (Lewis et al., 1972;
McLaren, 1972). For example, it is not clear how freely
the cells of the double- or triple-sized chimeric embryo
intermingle after aggregation and whether the ill-under-
stood size reduction which occurs before gastrulation275 (2004) 192–201
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1982). The problems inherent in the chimeric approach
were avoided in subsequent fate mapping studies that
were based upon mosaic animals generated by the
retroviral infection of preimplantation embryos that
genetically labeled individual blastomeres (Soriano and
Jaenisch, 1986). This approach, which does not disrupt
cell–cell interactions of the embryo leads to the estimate
that, in undisturbed development, eight cells are set aside
to form all somatic lineages of the animal. Chimeric mice
can also be generated by the injection of embryonic stem
(ES) cells into host blastocysts. Some of the experiments
described in this study were performed with the goal to
estimate the number of ES cells that contribute to the
somatic lineages of the resulting chimera. Such experi-
ments, while directly addressing the founder cell number
question in ES-chimeric mice, would also help to gain
further insights into the founder cell number problems
during normal embryogenesis.
ES cells are widely used for the genetic manipulation of
mice. Usually, genetically modified ES cells are injected
into 2n blastocysts to generate chimeric mice, which are
composed of the modified donor cells and cells derived
from the host embryo (Hooper et al., 1987; Jaenisch, 1988;
Robertson and Bradley, 1986). Contribution of the donor
ES cells to the germ line of the chimeric mice allows the
generation of mouse strains that carry the genetic mod-
ification. Alternatively, mice derived entirely from ES cells
(bES miceQ) can be generated by injecting ES cells into 4n
instead of 2n blastocysts, a method often called bES-
tetraploid complementationQ (Eggan et al., 2001; Nagy et
al., 1990). In this approach, ES cells give rise to the
epiblast, and the 4n host cells give rise only to the placenta
(Nagy et al., 1990), allowing us to study the consequences
of genetic manipulation without the need for germ line
transmission. Because ES cells tolerate consecutive gene
targeting cycles including selection by different antibiotics
without losing their developmental potency, multiple
mutations and/or transgenes can be introduced into a single
ES cell clone, and mice carrying these genetic changes can
be derived without further breeding (Eggan et al., 2002).
As a result, ES-tetraploid complementation facilitates the
generation of compound transgenic or mutant mice in a
shorter period of time compared to the chimeric approach.
ES-tetraploid complementation is achieved either by
injecting ES cells into 4n blastocysts or by aggregating
ES cells with four-cell stage 4n embryos (Eggan and
Jaenisch, 2003; Nagy et al., 1993). When injection is
employed as the method to generate ES mice, usually about
10 to 15 ES cells are injected into a 4n host blastocyst.
Previously, we showed that the donor ES cells must be
derived from F1 hybrid mice for efficient tetraploid
complementation (Eggan et al., 2001). Following transfer
of the embryos into the uterus of a pseudopregnant female,
up to 20% of the injected blastocysts develop into mice that
are exclusively composed of the donor ES cells.Similar to normal embryogenesis, many important bio-
logical questions concerning ES cell chimerism and ES
mouse formation have not been adequately addressed. For
example, it is unknown how many of the injected cells
eventually contribute to the animal and thus become founder
cells for the embryo proper. It is also unknown what the
minimum number of ES cells is that can create an ES
mouse. From an ES cell pluripotency point of view, it is not
clear whether individual ES cell clones derived from the
same parental ES cell line have the same potential to direct
embryogenesis after having been injected into 4n mouse
blastocysts. Thus, to better understand the cellular events
that are involved in the formation of chimeric or ES mice
and to shed some light on ES cell pluripotency in the
context of embryogenesis, we have studied the fate of the
injected ES cells in the resulting animal. For this, individual
donor ES cells were labeled with a genetic marker that
allowed tracing of the cells in the postnatal animal. Southern
analysis of the somatic tissues from chimeric or ES mice
demonstrated that there is a limited number of ES cells;
most often only one to two and, sometimes up to three, can
contribute to an embryo regardless of the number of ES cells
injected.Materials and methods
ES cells and tissue culture
The ES cells used for producing ES mice and chimeras
in this study were an F1 (129SvJaeC57BL/6) line (V6.5).
ES cell culture was carried out following standard
procedures (Hogan et al., 1986). Before blastocyst injec-
tion, ES cells were trypsinized, resuspended in ES culture
medium, and then plated on a standard 10 cm2 tissue
culture dish for 30 min to allow feeder cell attachment. ES
cells were then harvested from the supernatant by
centrifugation and were resuspended in 0.5 ml ES culture
medium.
Retroviral marking of ES cells by MSCV
Production of murine stem cell virus (MSCV) and
retroviral infection of V6.5 ES cells were carried out as
described (Cherry et al., 2000). Individually marked ES cell
clones were derived by picking and expanding puromycin-
resistant colonies after retroviral infection.
Detection of proviral genomes
Genomic DNA from ES cells or somatic tissues was
isolated by the simplified procedure (Laird et al., 1991),
digested by EcoRI (unless otherwise indicated), resolved by
0.8% agarose gel, transferred to GeneScreen membrane by
the alkaline transfer protocol (Life Science), and probed
with the puromycin gene.
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injection
B6D2F1 females were superovulated by i.p. injection of
7.5 U of pregnant mares’ serum (PMSG, Calbiochem) and
46–48 h later by 7.5 U of human chorionic gonadotrophin
(HCG, Calbiochem). After administration of HCG, females
were mated with B6D2F1 males. Fertilized zygotes were
isolated from oviducts 18–24 h post-HCG injection (day
0.5). Zygotes were incubated with M2 medium (Sigma)
containing 0.1% bovine testicular hyaluronidase for several
minutes at room temperature to remove any remaining
cumulus cells. Cumulus-free zygotes were washed three
times into a drop of KSOM medium (Specialty Media)
and cultured at 378C with an atmosphere of 5% CO2 in
air.
For 2n blastocysts injection, embryos were continually
cultured in KSOM to day 3.5 until the embryos became
fully expanded blastocysts. For generating 4n embryos,
zygotes were cultured overnight in KSOM to obtain two-
cell embryos, and the blastomeres of two-cell embryos
were electrofused to produce one-cell 4n embryos. Two-
cell blastomere fusion was carried out in fusion medium
(0.3 M mannitol, 0.3% BSA, Sigma) with two DC pulses
using a LF101 Electro Cell Fusion unit (Protech Interna-
tional, Inc.). Two-cell embryos were first equilibrated in the
fusion medium for about 1 min and then transferred to the
fusion chamber (CUY 5010, Protech International, Inc.).
Prepulse and postpulse AC (5 V/mm with a frequency of 1
MHz) were used to align the two-cell embryos perpendic-
ularly to the electrical field. Cell fusion was induced by
two DC pulses of 75 V/mm, each for 35 As with a 0.5-s
interval. Manipulation of a single group took less than 5
min. After electrofusion, embryos were returned to KSOM
medium to be kept at 378C with an atmosphere of 5% CO2
in air. The manipulated embryos were checked for fusion
30 min after electrofusion (fusion normally takes place in
about 20 min). Embryos that had not undergone membrane
fusion were discarded. Fusion efficiency is normally above
90%.
Blastocyst injection
Blastocysts, 2n or 4n (94–98 h post-HCG injection),
were placed in a drop of DMEM containing 15% FCS
under mineral oil. A flat-tip microinjection pipette with an
internal diameter of 12–15 Am was used for ES cell
injection. Up to 50 ES cells were picked up into the end of
the injection pipette. The blastocyst to be injected was held
in the vicinity of the inner-cell mass with a standard
holding pipette. The injection pipette containing ES cells
was pressed against the zona opposite the inner-cell mass.
A brief pulse of Piezo (Primetech, Ibaraki, Japan) was
applied, and the injection needle was simultaneously
pushed through the zona and trophectoderm layers into
the blastocoel cavity of the blastocyst (Kawase et al.,2001). A controlled number of ES cells were injected into
the blastocyst cavity. After injection, blastocysts were
returned to KSOM medium and placed at 378C until
transferred to recipient females.
Recipient females and cesarean sections
Ten to twelve injected blastocysts were transferred to
each uterine horn of 2.5 days postcoitum pseudopregnant
B6D2F1 females. To recover full-term ES or chimeric pups,
recipient mothers were sacrificed at 19.5 days postcoitum.
Surviving pups were either sacrificed to harvest organs for
genomic DNA extraction or fostered to lactating BALB/c
mothers.Results
Strategy to identify the number of ES founder cells in ES
mice by retroviral marking
To retrospectively determine the number of founder ES
cells that contribute to the formation of an ES mouse, a
stable genetic marker was needed to distinguish their
descendents in the tissues of the resulting animal. For this,
we used retroviral tags to individually mark the donor ES
cells. To generate a donor cell population with distinct
proviral markers, we infected ES cells with the murine
stem cell virus (MSCV) carrying the puromycin drug
resistance gene (Fig. 1A). The infected cells were treated
with puromycin, and 96 ES drug-resistant colonies were
picked and expanded. DNA from these individual ES cell
clones was extracted, digested with EcoRI, and subjected
to Southern analysis using the puromycin gene as probe.
Because EcoRI cuts once in the proviral genome, a single
band from the Southern blots corresponds to a single copy
of the proviral genome, and the unique size of the band
indicates its unique integration site in the ES cell genome
(Fig. 1B). As shown in Fig. 1B, most of the derived ES
cell clones carry a single copy of the proviral genome. In
the analyses described below, equal numbers of cells
carrying distinct proviral integrants were mixed to generate
a stock of ES cells with a known fraction of individually
marked cells for tetraploid complementation. Consequently,
Southern analysis would allow the retrospective determi-
nation of the number of the ES founder cells based on the
number of proviral copies in the somatic tissues of an
animal.
To determine the sensitivity of detecting a proviral band
on Southern blots, DNA from an ES cell clone carrying a
single provirus was serially diluted with control DNA and
subjected to Southern analysis. Fig. 1C shows that the
proviral band was easily distinguishable after 8-fold and still
detectable after 16-fold dilution of the ES cell DNA,
demonstrating that this analysis is sensitive enough to
reliably detect the contribution of an individual ES cell at a
Fig. 1. Individually marking ES cells by retroviral infection. (A) Restriction map of the murine stem cell virus (MSCV) genome. All the restriction sites indicated
on the MSCV vector are unique. EcoRI (unless otherwise indicated) was used to digest the genomic DNA of the MSCV-infected ES cell clones for Southern
blotting. Blots were probed against the puromycin gene. (B) An example of Southern blots showing some of the ES cell clones marked by MSCV infection. The
arrowhead indicates a nonspecific background band which is also observed in somatic genomic DNA extracted from the tails of several strains of mice (C57, Balb/
c, 129, and DBA2. Data not shown). Note that all of the proviral bands from the 10 ES cell clones chosen for study (indicated by stars) are distinguishable from the
background band. (C) Detection sensitivity of Southern blotting by the puromycin probe. DNA from an MSCV-labeled ES cell clone (ES7) was serially diluted
with control DNA and subjected to Southern analysis with the puromycin probe. Loading of DNA samples on each lane was verified by a probe against ColA1.
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Previously, we showed that, during normal mouse embryo-
genesis, there are approximately 8 to 10 founder cells for theTable 1
Summary of ES mice produced with 15, 10, or 5 ES cell injections
Number of ES
cells injected/
blastocyst
Number of
blastocysts
injected
Number of
ES mice
produced (%)
Number of
1 Founder
15 43 3 (6.9%) 1
10 96 8 (8.3%) 3
5 158 10 (6.3%) 4
The ES cell clones used for tetraploid complementation were at passage 2 after eentire somatic lineage (Soriano and Jaenisch, 1986). Thus,
our assay is sensitive enough to detect as few as 1 out of a
total of 10 founder ES cells in the somatic tissues.mice with different numbers of founder ES cells per mouse
2 Founders 3 Founders
2 0
2 3
4 2
stablishment from retroviral infection.
Fig. 2. Detection of the proviral genome(s) in somatic tissues of ES mice by Southern blotting. Genomic DNA was digested by EcoRI and probed with the
puromycin probe to reveal the number of founder ES cells. (A) Tail DNA from ES mice T5 and T6 (15 cells injected per blastocyst), T10 and T11 (10 cells
injected per blastocyst), T8, T9, T20, and T21 (5 cells injected per blastocyst), and T22 (1 cell injected per blastocyst, see below). The last lane is DNA from an
equal mixing of eight ES cell clones (8mix). The arrowhead indicates the background band. (B) All three germ layers of ES mice are derived from a common
pool of founder ES cell(s) (also see Fig. 3B). Multiple tissues representing all the three germ layers were also analyzed for each ES mouse. Shown here are the
results from T7 (produced by injecting 15 ES cells per blastocyst) and T10 (produced by injecting 10 ES cells per blastocyst). Tissues from mouse T7 shown
here are brain (B), heart (H), kidney (K), liver (Li), lung (Lu), spleen (Sp), and tail (Ta); tissues from mouse T10 shown here are brain (B), heart (H), liver (Li),
kidney (K), lung (Lu), skin (Sk), and tail (Ta).
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Fig. 3. Southern analysis of somatic tissues from ES mice produced from
mixing 48 individually marked ES cell clones. Brain (B), heart (H), and
liver (L) tissues representing each of the three germ layers were chosen for
Southern analysis. The figure shows only the results (A) from brains of
mice T1 to T4 (EcoRI digestion) and (B) from tissues representing the three
germ layers in mouse T3 (HindIII digestion).
Table 2
Frequency with which each ES cell clone contributed to the somatic tissues
of ES mice or chimeras
ES clones Number of times an ES cell clone was detected in
the somatic tissues
ES mice Chimeras
ES1 3 1
ES2 6 3
ES3 5 2
ES4 2 3
ES5 9 2
ES6 3 1
ES7 2 0
ES8 4 0
ES9 4 0
ES10 1 4
Table summarizes 21 ES mice and 11 chimeras produced from these 10 ES
cell clones.
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ES cells
To generate a defined ES cell donor population for
tetraploid complementation, we chose 10 ES cell clones
(designated as ES1 to ES10) that were uniquely marked
with single proviral integrations (clones indicated by stars in
Fig. 1B). These 10 ES cell clones were grown separately
and mixed in equal numbers before injection. To generate
ES mice, 5, 10, or 15 ES cells from the mixed stock were
injected into 4n blastocysts, and the reconstituted embryos
were transferred into the uteruses of foster females. We
found that, independent of the number of ES cells injected
per blastocyst, approximately 6% to 8% (Table 1) of the
embryos developed to healthy full-term pups as judged by
gross morphology and their ability to successfully initiate
normal breathing. The remaining blastocysts were either
arrested at early gestation stages or developed to term but
failed to initiate normal breathing (approximately 2% to 4%
of the injected blastocysts). To avoid analysis of abnormal
pups, we harvested somatic tissues only from ES mice that
successfully initiated normal breathing. In total, we gen-
erated 21 ES mice for analysis (Table 1). The frequency of
generating ES mice in these experiments was lower than
that reported in a previous study (Eggan et al., 2001). This
difference in efficiency may be due to experimental
variations including a later passage number of the V6.5
ES cells or because the manipulations were performed by a
different investigator.
To identify the number of ES founder cells that
contributed to the somatic tissues, DNA from different
organs was isolated and analyzed by Southern blotting.Fig. 2A is an example of such an analysis and shows that
one, two, or at most three proviral bands, irrespective of
the numbers of ES cells injected per blastocyst, were
present in the somatic tissue (summarized in Table 1).
Furthermore, all the somatic tissues in a given ES mouse
showed an identical pattern of proviral bands (Fig. 2B;
also see Fig. 3B). This indicates that the injected ES cells
intermingle extensively before lineage allocation takes
place and that all the somatic lineages were derived from
a common pool of founder ES cells. Importantly, cells
from all of the 10 ES cell clones were capable of
contributing to ES mice as indicated by the presence of
their respective proviral bands in the somatic tissues
(summarized in Table 2, column 2). This demonstrated
that all the ES cell clones are potent in directing
embryogenesis after being injected into 4n blastocysts.
Since up to 15 ES cells from the pool consisting of 10
individually labeled ES cells were injected into a 4n
blastocyst, it was possible that several cells from the same
clone contributed to the embryo. To reduce the probability
that more than one cell of the same clone was injected into
the blastocysts, we generated another stock of ES cells
consisting of an equal number of 48 individually labeled
ES cell clones. ES mice were generated by injection of 10
ES cells per blastocyst and were analyzed by Southern
blotting. In addition to the Southern analysis when EcoRI
was used for cutting the DNA, DNA from each mouse was
also analyzed after HindIII (another unique cutter in the
proviral genome) digestion. We confirmed that each
proviral band on Southern blots represents only one ES
cell clone. Fig. 3A shows that, as before, the ES mice were
derived from only one or two founder ES cells. Again,
somatic tissues representing the three germ layers in an ES
mouse were found to have an identical pattern of proviral
bands (Fig. 3B). Thus, we conclude that the entire somatic
lineage of ES mice often derives from only one or two
founder ES cells.
Fig. 4. Detection of the proviral genome(s) in the somatic tissues of chimeric mice by Southern blotting. Tail DNA from full-term pups was cut by EcoRI and
probed against the puromycin gene. The bands representing each of the proviral genomes are marked by stars. Arrows indicate the proviral genomes, and the
arrowhead indicates the background band. Figure shows the results from 17 pups produced from a single injection experiment. D1 to D11 are chimeras, and M1
to M6 are nonchimeric mice.
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founder cells that contribute to chimeric mice derived from
the injection of ES cells into 2n blastocysts. About 10 ES
cells taken from the same pool of the 10 individually
marked ES cell clones used for tetraploid complementation
described above were injected into each 2n blastocyst.
From a total of 48 injected blastocysts, 17 full-term pups
were produced. Among them, 10 pups were found to carry
one or two founder ES cells, and only one pup carried
three founder ES cells (Fig. 4 and Table 3). The other six
pups were nonchimeric. Similar to the ES mice, the
founder ES cells contributed equally to all tissues in the
chimeras (not shown). Table 2 (column 3) shows that most
of the ES cell clones in the donor pool contributed to the
chimeric mice.
In conclusion, the data summarized in Tables 1 and 3
suggest that one, two, or at most three donor ES cells
contribute to the formation of ES or chimeric mice when
five or more ES cells are injected per blastocyst.Table 3
Number of founder ES cells detected in the somatic tissues of chimeric mice
Number of ES
cells injected/
blastocyst
Number of
pups analyzed
Number of chimeras
(% of pups analyzed)
10 to 15 17 11 (65%)
The ES cell clones used for diploid blastocyst injection were the same as used foES mice can be derived from a single ES cell injected into a
tetraploid blastocyst
The results described above showed that ES mice are
frequently derived from only a single founder cell that is
sampled from a pool of 5 to 15 injected cells. To
investigate whether the injection of a single cell is
sufficient to generate an ES mouse, we subjected 4n
blastocysts to single cell injections. As summarized in
Table 4, only one viable ES mouse was derived from 192
injected blastocysts (0.5%). Thus, ES mice can be derived
from 4n blastocysts that have been injected with a single
ES cell, albeit with extremely low efficiency. The
production of chimeric mice from 2n blastocysts that had
been injected with single ES cells was more efficient as two
chimeric mice developed from 23 2n blastocysts injected
with a single ES cell (9%).
Since the first step in the generation of ES mice is the
colonization of the injected ES cells into the host blastocyst,Number of founder ES cells per chimera
1 Founder 2 Founders 3 Founders
7 3 1
r tetraploid complementation.
Table 4
Efficiency of producing ES mice or chimeras by single ES cell injections
Blastocyst
injected
Number of
blastocysts
injected
Number
of mice
produced
(%)
Tetraploid 192 1 (.5)
Diploid 23 2 (8.7)
Table 5
Colonization of ES cells in host blastocysts in vitro
Blastocyst
injected
Number of
ES cells
injected/
blastocyst
Number of
blastocysts
injected
Number of
GFP-positive
blastocysts 24 h
post injection
(%)
Tetraploid 1 26 9 (34.6%)
2 15 9 (60.0%)
3 19 16 (84.2%)
4 18 15 (83.3%)
5 18 15 (83.3%)
Diploid 1 25 15 (60.0%)
2 17 16 (94.1%)
3 15 14 (93.3%)
4 22 20 (90.9%)
5 30 28 (93.3%)
Different numbers of GFP+ ES cells were injected into tetraploid or diploid
blastocysts and their colonization into the host blastocysts was examined 24 h
post injection.
Z. Wang, R. Jaenisch / Developmental Biology 275 (2004) 192–201 199the low efficiency in producing ES mice by single ES cell
injections may be a reflection of the low efficiency of a
single ES cell to colonize the host blastocyst. To test this, we
injected different numbers of GFP-labeled ES cells into 4n
blastocysts (and as a comparison also into 2n blastocysts)
and cultured the reconstituted embryos in vitro. Twenty-four
hours after injection, the incorporation of GFP-positive ES
cells into the injected blastocysts was examined. As shown
in Fig. 5 and summarized in Table 5, the fraction of GFP-
positive blastocysts depended on the number of injected ES
cells. Injection of one or two ES cells into 4n blastocysts
generated about 35% and 60% green blastocysts, respec-
tively, whereas the injection of three or more cells increased
the proportion of GFP-positive embryos to more than 80%.
Injection of one ES cell into 2n blastocysts generated 60%
chimeric embryos, whereas the injection of two or more
cells increased the fraction of GFP-labeled embryos to more
than 90%. These results suggest that efficient colonizationFig. 5. Colonization of ES cells into 4n host blastocysts in vitro.
Blastocysts, 4n or 2n, were injected with different number of GFP-positive
ES cells, and their colonization into the host blastocysts was examined 24 h
after injection. The figure shows only the GFP-positive 4n blastocysts 24 h
after injection. (A) One, (B) two, (C) three, or (D) four and five ES cells
were injected.of the ICM in a 4n embryo requires the injection of at least
three ES cells.
Growth characteristics of donor ES cells
One possibility to explain the small number of ES cells
contributing to an ES mouse would be that the host embryo
has a yet uncharacterized mechanism to restrict the number
of founder cells, a phenomenon seen in normal mouse
embryogenesis (Soriano and Jaenisch, 1986). When multi-
ple ES cells are injected into a 4n embryo, the injected ES
cells likely compete with each other as well as with the
cells in the host embryo. To assess whether some clonally
derived cells in a stock of ES cells have a growth
advantage in vitro and whether the ability to preferentially
colonize the embryo after blastocyst injection correlated
with in vitro growth rate, we mixed equal cell numbers
from eight of the ES cell clones used for the generation of
ES mice described above. Equal mixing was ascertained by
Southern analysis of the stock using the puromycin gene as
probe (Fig. 6, lane 1). The cell population was then serially
passaged, and at each passage, the relative intensity of the
proviral bands was monitored by Southern analysis. Fig. 6
shows that the relative intensity of a proviral band
corresponding to clone ES5 increased relative to other
proviral bands during passaging, indicating that this ES cell
clone grew faster. In addition, when five ES mice produced
from the cell population at passage 10 were analyzed, clone
ES5 was found to contribute to four out of the total six
founders identified in these mice (data not shown). More
importantly, when all the ES mice produced from equal cell
number mixing of the 10 ES cell clones were compared for
clonal contributions, we found that ES5 was the clone that
was most represented in the somatic tissues (see Table 2).
These results are consistent with the interpretation that
donor cells that have an in vitro growth advantage may
Fig. 6. In vitro growth competition among ES cell clones. An equal number
of ES cells from eight individually marked ES cell clones (ES1, 2, 3, 4, 5, 6,
8, and 10) were grown together and passaged 10 times. Genomic DNA
from ES cells at passage 0 (before growing), 4, 6, 8, and 10 was analyzed
by Southern blotting.
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mice.Discussion
To generate ES mice, between 10 and 15 cells are
usually injected into a host blastocyst. Here, we show
that only between one and two or at most three of the
injected ES cells will contribute to the formation of the
somatic lineages. This is a substantially smaller number
of founder cells than that found in normal development,
where the number of cells that form the epiblast lineage
has been estimated to be about eight cells (Soriano and
Jaenisch, 1986). In the 2n host, the injected ES cells haveto compete throughout development with host-derived
cells in contrast to the situation in the 4n host embryo
where the 4n host cells are eliminated from colonizing
the somatic lineages of the animal. Our results suggest,
however, that both 2n and 4n host embryos impose
similar constraints on the number of ES cells that can
contribute to the chimeric or ES cell mouse, respectively.
Although it has been shown that all 4n host cells have
been eliminated by E 13.5 of development (Wang et al.,
1997), it is not clear when selection against the 4n host
cells occurs. It is possible that the 4n cells are eliminated
from the epiblast lineage only at some time after
implantation. Thus, in both 2n and 4n host blastocysts,
the initial competition between donor ES and host cells
may be similar. In 4n embryos, the host cells are
eventually eliminated, in contrast to 2n host embryos
where competition between host and donor cells persists
throughout development.
Our observation that the number of ES cells that
contributes to the embryonic lineage was independent of
the total number of injected ES cells suggests that
constraints imposed by the host blastocyst limit the number
of cells that can colonize the developing embryo. Our results
are consistent with the notion that host and donor cells
compete for a space or a bnicheQ in the ICM and/or at an
early stage after implantation to contribute to the somatic
lineages. It may be that the number of cells occupying this
bnicheQ is limited and cannot, in addition to the endogenous
host cells, accommodate more than three donor founder
cells. Thus, regardless of whether 5, 10, or 15 cells are
injected into the 4n blastocyst, in most cases only one or two
and occasionally up to three of the injected cells are able to
compete with the host cells and are selected as founder cells
to generate the epiblast lineage. Previous mosaic studies
suggested that eight cells serve as founders of the somatic
lineages in normal development (Soriano and Jaenisch,
1986), but it is not clear whether the bnicheQ can
accommodate additional, ES cell-derived founder cells in
the chimeric embryo.
Participation of the donor ES cells in colonizing the
host embryo may be constrained at several points in the
development of the animal. It was shown that, when
single ES cells were injected into an eight-cell stage
mouse embryo, they could undergo one to two cycles of
mitosis between the eight-cell and the blastocyst stage,
whereas those injected as groups of two to five cells did
not proliferate during the same period of development
(Saburi et al., 1997). This suggests that the host embryo
can control the survival and proliferation of injected ES
cells as early as at the preimplantation stages. Our results
do not exclude the possibility that aggregation of ES
cells with morula stage host embryos (Tanaka et al.,
2001) alters their potential to contribute to the somatic
lineages.
Another constraint to contributing to the host embryo is
the minimum number of ES cells that are introduced into
Z. Wang, R. Jaenisch / Developmental Biology 275 (2004) 192–201 201the blastocyst. Thus, by tracing GFP-labeled ES cells, we
have shown that at least three cells need to be injected for
the ES cells to efficiently colonize the host embryo. After
injection into the blastocoel, ES cells have to translocate
and integrate into the ICM to participate in subsequent
development. The much lower efficiency of producing ES
mice with single cell injections may be partially due to an
insufficient contact between the ES cell and the ICM.
Multiple ES cell injections may increase the chance for ES
cells to translocate to the ICM. It is also possible that
multiple ES cells injected into a host blastocyst provide
some paracrine factors which support their initial survival
and hence increase the chance of colonizing the host
blastocyst. Finally, it is conceivable that both genetic and
epigenetic abnormalities may occur in ES cells during
cultivation (Eggan et al., 2002), thus not every single ES
cell is fully potent to support embryogenesis. In this regard,
the efficiency of generating ES mice with single cell
injections would be disproportionably decreased, as com-
pared to multiple cell injections where fully potent ES cells
are not at the limit in the injected blastocysts.
We found that some of the ES cell clones such as ES2
and ES5 contributed more frequently to ES mice than
others, suggesting that these clones had a selective
advantage over other clones. In principle, selection could
occur during culture or after injection into the host
blastocyst. In vitro cultivation of the ES cell pool revealed
more vigorous growth of clone ES5 which predominated
in the population after serial passage. Founder cells of ES
mice generated at this passage level were indeed primarily
derived from ES5. Our results are consistent with the
notion that ES cells that outcompete cells in vitro may
also have a competitive advantage in the embryo.
Importantly, there was no significant difference in aneu-
ploidy among these ES cell clones since our karyotyping
assay showed that all of these ES cell clones were about
90% euploid (data not shown). Finally, similar to normal
development, we found that all founder ES cells con-
tributed equally to all somatic tissues, indicating extensive
cell mixing before tissue allocation (Soriano and Jaenisch,
1986).
The generation of ES mice has become an important
tool to generate genetically modified mice. Our observa-
tions define some of the parameters that affect the
efficiency of producing ES mice. However, issues such
as the mechanisms leading to host cell elimination remain
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